Literature DB >> 8032938

Microinfusion of corticotropin releasing factor into the locus coeruleus/subcoeruleus nuclei stimulates colonic motor function in rats.

H Mönnikes1, B G Schmidt, J Tebbe, C Bauer, Y Taché.   

Abstract

Convergent evidence indicates that brain corticotropin-releasing factor (CRF) participates in stress-related alterations of gastric and colonic motor function. CRF in the locus coeruleus has been shown to induce anxiogenic response. Whether the locus coeruleus/subcoeruleus nucleus (LC/SC) is a site of action for CRF to alter gastric and colonic transit was investigated in conscious, chronically cannulated rats. CRF (0.2 nmol) microinjected into the LC/SC did not influence gastric emptying of a non-caloric semi-liquid meal while stimulating colonic transit by 57% as assessed by the geometric center in fasted rats. Under the same conditions, i.c.v. injection of CRF (0.2 nmol) delayed gastric emptying by 31% and increased colonic transit by 103%. When colonic transit was evaluated as the time of appearance in the feces of a marker placed in the proximal colon, CRF (0.2 nmol) injected into the LC/SC or i.c.v. stimulated colonic transit by 77% and 48% respectively and fecal output/6h by 3.8 and 2.8 fold respectively. Microinjection of CRF into the medial and lateral parabrachial nucleus, postero-dorsal tegmental nucleus, dorsomedial tegmental area and the ventral part of the nucleus subcoeruleus did not influence colonic transit. These data indicate that CRF acts in the LC/SC to induce a long lasting stimulation of colonic transit and bowel discharge without influencing gastric emptying. These findings suggest a possible role of the LC/SC in the regulation of colonic motor function and of endogenous CRF at these sites in the stress-related activation of colonic motor function.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8032938     DOI: 10.1016/0006-8993(94)90352-2

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  26 in total

1.  Regulation of hepatic function by brain neuropeptides.

Authors:  Masashi Yoneda
Journal:  World J Gastroenterol       Date:  1998-06       Impact factor: 5.742

2.  Visceral analgesia induced by acute and repeated water avoidance stress in rats: sex difference in opioid involvement.

Authors:  M Larauche; A Mulak; Y S Kim; J Labus; M Million; Y Taché
Journal:  Neurogastroenterol Motil       Date:  2012-07-09       Impact factor: 3.598

3.  Mice overexpressing wild-type human alpha-synuclein display alterations in colonic myenteric ganglia and defecation.

Authors:  L Wang; I Magen; P-Q Yuan; S R Subramaniam; F Richter; M-F Chesselet; Y Taché
Journal:  Neurogastroenterol Motil       Date:  2012-07-11       Impact factor: 3.598

Review 4.  Corticotropin-releasing factor receptors and stress-related alterations of gut motor function.

Authors:  Yvette Taché; Bruno Bonaz
Journal:  J Clin Invest       Date:  2007-01       Impact factor: 14.808

5.  Organization and Integration of the Endocrine System.

Authors:  George P Chrousos
Journal:  Sleep Med Clin       Date:  2007-06

Review 6.  Trauma and the gut: interactions between stressful experience and intestinal function.

Authors:  R Stam; L M Akkermans; V M Wiegant
Journal:  Gut       Date:  1997-06       Impact factor: 23.059

Review 7.  Central nervous system control of gastrointestinal motility and secretion and modulation of gastrointestinal functions.

Authors:  Kirsteen N Browning; R Alberto Travagli
Journal:  Compr Physiol       Date:  2014-10       Impact factor: 9.090

8.  Cholinergic giant migrating contractions in conscious mouse colon assessed by using a novel noninvasive solid-state manometry method: modulation by stressors.

Authors:  G Gourcerol; L Wang; D W Adelson; M Larauche; Y Taché; M Million
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2009-03-19       Impact factor: 4.052

Review 9.  CRF1 receptor signaling pathways are involved in stress-related alterations of colonic function and viscerosensitivity: implications for irritable bowel syndrome.

Authors:  Y Taché; V Martinez; L Wang; M Million
Journal:  Br J Pharmacol       Date:  2004-04       Impact factor: 8.739

10.  Effect of a corticotropin releasing hormone receptor antagonist on colonic sensory and motor function in patients with irritable bowel syndrome.

Authors:  Y Sagami; Y Shimada; J Tayama; T Nomura; M Satake; Y Endo; T Shoji; K Karahashi; M Hongo; S Fukudo
Journal:  Gut       Date:  2004-07       Impact factor: 23.059

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.